NUHEARA LIMITED (NUH)

The securities of Nuheara Limited were suspended by ASX on 1 March 2024 for not lodging the relevant periodic report by the due date. Having regard to the announcement on 7 August 2024 of the appointment of voluntary administrators of NUH and its subsidiaries, ASX has determined that NUH's financial condition is not adequate to warrant the continued quotation of its securities and therefore is in breach of Listing Rule 12.2. Accordingly, NUH's securities will now continue to be suspended from quotation under Listing Rule 17.3. The suspension will continue until such time that ASX is satisfied with NUH's compliance with the Listing Rules, including Listing Rule 12.2 and that it is otherwise appropriate for NUH's securities to be reinstated to quotation.

Nuheara Limited's Directors appointed Martin Jones, Matthew Woods, and Clint Joseph as Joint and Several Voluntary Administrators to facilitate the company's Strategic Review due to the maturing of its $2.5m convertible note with Realtek Semiconductor Corporation. The Directors will continue working with Realtek to execute an executed Commercial and Royalty Agreement, which is crucial for the review process.

The company releases a notification regarding unquoted securities.

The company releases a notice of application for quotation of securities.

The company releases a notification of cessation of securities.

The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

The company informs shareholders that all resolutions at the General Meeting of Shareholders were voted on, as per Listing Rule 3.13.2 and section 251AA of the Corporations Act.

The company releases a letter to its shareholders regarding a notice of general meeting.

A general meeting of the Company will be held at the offices of RSM Australia Pty Ltd at Level 32, Exchange Tower, 2 The Esplanade, Perth, Western Australia on Monday, 24 June 2024 at 10.00am (AWST).

The business is shifting its strategy and currently restructuring its investment levels, including limiting new production and marketing spend, with a prioritisation on the completion of the new chip development with Realtek and the next generation of the HP Hearing PRO product. The Company has also undertaken a review of resourcing levels and all costs associated with these resources. The Strategic Review is ongoing, including active discussions with multiple potential M&A partners. Azure Capital Pty Ltd is advising the Company with the Strategic Review. The Company's shares are currently in a trading suspension pending the lodgement of its half yearly financial statements. Given the ongoing Strategic Review, the Board has determined that following the release of the financial statements, it will request from ASX a voluntary suspension of trading pending the conclusion of the Strategic Review.

The company lodges its Quarterly Activities Report.

The company lodges its Quarterly Appendix 4C.

The company releases a notification regarding unquoted securities.

The Company releases a prospectus for the offer of 10,279,624 options on the basis of one option for every three shares subscribed for by investors in the placement. This is a prospectus for the offer of 355,084 options to an advisor of the Company.

The company releases a notice of application for quotation of securities.

The company releases a notification of cessation of securities.

The company releases a notice of proposed issue of securities.

The Board has commenced a Strategic Review, with M&A considered the most appropriate strategy for the next phase of its evolution. The Company has secured commitments for $1.85 million in additional equity capital via a placement of shares to shareholders to support the completion of the Strategic Review. Following completion of the capital raise it is the Company's intention to seek to secure a return of its equity to trading on ASX, subject to satisfying all requirements of ASX.

The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Friday, 1 March 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 29 February 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.

The suspension of trading in the securities of Nuheara Limited will be lifted from the commencement of trading on Thursday, 9 March 2023 following lodgement of its Appendix 4D and half-year report for the period ended 31 December 2022.

The company lodges its Appendix 4D and Half Year Financial Report.

The company releases its Corporate Presentation.

The company releases a notice of proposed issue of securities.

Successful $3 million placement (before costs), to sophisticated and professional investors, at $0.17 per share. Funds raised support working capital to ramp up production for ongoing rollout of the Company's US FDA cleared OTC hearing aids. Placement cornerstoned by strategic investor, Taiwan based Realtek Semiconductor Corporation (Realtek), through $0.6 million (20%) commitment.

The entity's securities will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Wednesday, 1 March 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office yesterday and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.

The suspension of trading in the securities of Nuheara Limited will be lifted from the commencement of trading on Friday, 7 October 2022 following lodgement of its annual report to shareholders and Appendix 4G.

The company lodges its Annual Report and Appendix 4G and Corporate Governance Statement.

The company's AGM will be held at 9.00am (WST) on Tuesday, 29 November 2022 at the head office, 190 Aberdeen Street, Northbridge, Western Australia. A valid nomination for the position of Director must be received by the Company not less than 30 business days before the date of the annual general meeting (being 17 October 2022).

The company releases a notification of cessation of securities.

The securities of the company will be suspended from Official Quotation in accordance with Listing Rule 17.5 from the commencement of trading today, 3 October 2022, following their failure to lodge the relevant periodic report by the due date.

The suspension of trading in the securities of Nuheara Limited will be lifted immediately following the release by NUH of an announcement regarding a capital raising.

The company issues a notice of proposed issue of securities.

Nuheara has raised $2.5 million from Realtek, which follows a $1.7 million placement from Realtek on 1 July 2022. These funds further strengthen the Nuheara and Realtek partnership, designed to develop chipset and technology solutions to globally penetrate multiple hearing related markets. Funds will be used for product research and development, Medical Device/Hearing Aid market and regulatory development, and working capital. The Convertible Note will be issued under the Company's Listing Rule 7.1 placement capacity.

The securities of Nuheara Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of NUH, pending the release of an announcement regarding a potential capital raising.

The suspension of trading in the securities of Nuheara Limited will be lifted immediately following the release by NUH of an announcement regarding a capital raising.

The suspension of trading in the securities of Nuheara Limited will be lifted immediately following the release by NUH of an announcement regarding a capital raising.

The company releases a notice of proposed issue of securities.

The company has entered into a strategic partnership and cornerstone investment from Taiwan based Realtek Semiconductor Corporation. By way of a signed Memorandum of Understanding, Nuheara and Realtek will partner together to develop chipset and technology solutions to globally penetrate multiple hearing related markets. These include the global True Wireless Stereo with Personal Sound Amplification Product (PSAP) chipset market and the regulated Over The Counter Hearing Aid market.

The securities of Nuheara Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of NUH, pending the release of an announcement regarding a capital raising.

The suspension of trading in the securities of Nuheara Limited will be lifted immediately, following receipt of an announcement by the Company.

Nuheara Limited is pleased to confirm that it has received firm commitments from institutional and sophisticated investors to raise A$4.984 million at A$0.06 per share.

The securities of Nuheara Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement.

name changed from Wild Acre Metals Limited